Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats. [electronic resource]
Producer: 20171116Description: 77-81 p. digitalISSN:- 1521-7035
- Animals
- Antirheumatic Agents -- pharmacology
- Arthritis, Experimental -- immunology
- Arthritis, Rheumatoid -- immunology
- C-Reactive Protein -- drug effects
- CD4-Positive T-Lymphocytes -- drug effects
- Foot
- Foot Joints -- drug effects
- Forelimb
- Hindlimb
- Interferon-gamma -- immunology
- Interleukin-1beta -- drug effects
- Methotrexate -- pharmacology
- Piperidines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- RNA, Messenger -- drug effects
- Rats
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Spleen -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.